Genitourinary Cancers | Tumor

Matters of Faith After a Cancer Diagnosis

June 18th 2024, 3:00pm

Article

Leaning on spiritual belief may strengthen patients' life purposes, but for many, it's common to temporarily loosen their grip on faith after a cancer diagnosis.

Cancer Therapy at End of Life May Not Boost Survival

June 17th 2024, 9:00pm

Article

Patients who received systemic therapy at the end of life did not have longer overall survival averages than those who did not receive therapy at end of life.

Innovation and Resilience in the Genitourinary Cancer Space

June 15th 2024, 2:00pm

Article

Within the genitourinary cancer space, there have been many treatment advances over the past year.

Reflecting on My Two Cancer Triumphs on Father’s Day

June 14th 2024, 1:00pm

Article

I feel most thankful on Father's Day, especially after being told I'd never be able to have children.

Padcev Plus Keytruda Doesn’t Worsen Quality of Life in Bladder Cancer

June 7th 2024, 7:00pm

Article

Padcev and Keytruda improve survival and progression among patients with bladder cancer, but don’t adversely impact pain, functioning or quality of life.

Alonzo Mourning Has Prostate Cancer Surgery, ‘Felicity’ Actor Dies and More

June 7th 2024, 3:00pm

Article

From the NBA’s Alonzo Mourning opening up about his prostate surgery to an actor from “Felicity” dying of cancer, here’s what is happening in the oncology space this week.

Keytruda Plus Chemo May Improve Penile Cancer Outcomes

June 6th 2024, 7:00pm

Article

Keytruda plus platinum-based chemotherapy appeared to be safe and effective in treating penile squamous cell carcinoma.

Padcev Improves Outcomes for Cisplatin-Ineligible Bladder Cancer

June 6th 2024, 3:00pm

Article

For patients with cisplatin-ineligible bladder cancer, presurgical Padcev decreased the cancer stage without leading to delays in surgery.

A Poem About Finding Purpose and Looking Ahead During Cancer

June 5th 2024, 1:00pm

Article

Learning that I had cancer — melanoma and renal cell carcinoma — made me feel like I lost something, but I keep looking ahead.

Long-Term Postsurgical ADT May Reduce Prostate Cancer Metastasis Risk

June 4th 2024, 7:00pm

Article

Two years of postsurgical androgen deprivation therapy resulted in a 10-year metastasis-free survival rate of nearly 80%.